Concurrent activation of the somatosensory forebrain and deactivation of periaqueductal gray associated with diabetes-induced neuropathic pain

Experimental Neurology

Volumn 208, Issue 2, 2007, Pages 305-313

  Paulson, Pamela E ^a,b   Wiley, John W ^b   Morrow, Thomas J ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Behavior; Brain imaging; Experimental diabetes; Neuropathic pain; Streptozotocin

Indexed keywords

GLUCOSE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; STREPTOZOCIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BEHAVIOR; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIAGNOSTIC IMAGING; DISEASE DURATION; FOREBRAIN; GLUCOSE BLOOD LEVEL; HABENULA; HYPERGLYCEMIA; HYPERSENSITIVITY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MESENCEPHALON; NEUROIMAGING; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; SOMATOSENSORY CORTEX; STREPTOZOCIN DIABETES; THALAMUS NUCLEUS; THERMAL STIMULATION;

AMYGDALA; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CEREBROVASCULAR CIRCULATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; HABENULA; HYPERGLYCEMIA; MALE; NEURALGIA; PERIAQUEDUCTAL GRAY; PROSENCEPHALON; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SOMATOSENSORY CORTEX; TECHNETIUM TC 99M EXAMETAZIME; THALAMIC NUCLEI;

EID: 36049003725     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.09.001     Document Type: Article

References (53)

1. Benbow J., Chan A.W., Bowsher D., MacFarlane I.A., and Williams G. A prospective study of painful symptoms, small-fibre function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabet. Med. 17 (1994)
2. Biessels G.J. Cerebral complications of diabetes: clinical findings and pathogenetic mechanisms. Neth. J. Med. 54 (1999) 35 (Review, 162 refs)
3. Biessels G.J., and Gispen W.H. The impact of diabetes on cognition: what can be learned for rodent models?. Neurobiol. Aging 265 (2006) S36-S41
4. Biessels G.J., Cristino N.A., Rutten G.J., Hamers F.P., Erkelens D.W., and Gispen W.H. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment. Brain 122 (1999) 757
5. Biessels G.J., Cristino N.A., Rutten G.J., Hamers F.P.T., Erkelens D.W., and Gispen W.H. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats-course of development and effects of insulin treatment. Brain 122 (1999) 757
6. Brands A.M., Kessels R.P., de Haan E.H., Kappelle L.J., and Biessels G.J. Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels. European Journal of Pharmacology 490 (2004) 159 (Review, 115 refs)
7. Britland S.T., Young R.J., Sharma A.K., and Clarke B.F. Acute and remitting painful diabetic polyneuropathy: a comparison of peripheral nerve fibre pathology. Pain 48 (1992) 361-370
8. Burchiel K.J., Russell L.C., Lee R.P., and Sima A.A. Spontaneous activity of primary afferent neurons in diabetic BB/Wistar rats. A possible mechanism of chronic diabetic neuropathic pain. Diabetes 34 (1985) 1210
9. Calcutt N.A. Potential mechanisms of neuropathic pain in diabetes. Int. Rev. Neurobiol. 50 (2002) 205
10. Calcutt N.A. Potential mechanisms of neuropathic pain in diabetes. Int. Rev. Neurobiol. 50 (2002) 205 (Review, 149 refs)
11. Calcutt N.A., Chen P., and Hua X.Y. Effects of diabetes on tissue content and evoked release of calcitonin gene-related peptide-like immunoreactivity from rat sensory nerves. Neurosci. Lett. 254 (1998) 129
12. Calcutt N.A., Freshwater J.D., and O'Brien J.S. Protection of sensory function and antihyperalgesic properties of a prosaposin-derived peptide in diabetic rats. Anesthesiology 93 (2000) 1271
13. Calcutt N.A., Stiller C.O., Gustafsson H., and Malmberg A.B. Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats. Brain Res. 856 (2000) 20
14. Chen X., and Levine J.D. Altered temporal pattern of mechanically evoked C-fiber activity in a model of diabetic neuropathy in the rat. Neuroscience 121 (2003) 1007
15. Comi G. Evoked potentials in diabetes mellitus. Clinical Neuroscience 4 (1997) 374 (Review, 59 refs)
16. Courteix C., Eschalier A., and Lavarenne J. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 53 (1993) 81
17. Di Giulio A.M., Tenconi B., La Croix R., Mantegazza P., Abbracchio M.P., Cattabeni F., and Gorio A. Denervation and hyperinnervation in the nervous system of diabetic animals. II. Monoaminergic and peptidergic alterations in the diabetic encephalopathy. J. Neurosci. Res. 24 (1989) 362
18. Di Giulio A.M., Tenconi B., La Croix R., Mantegazza P., Cattabeni F., and Gorio A. Denervation and hyperinnervation in the nervous system of diabetic animals. I. The autonomic neuronal dystrophy of the gut. J. Neurosci Res. 24 (1989) 355
19. Dyck P.J., Lambert E.H., and O'Brien P.C. Pain in peripheral neuropathy related to rate and kind of fiber degeneration. Neurology 26 (1976) 466-471
20. Forman L.J., Estilow S., Lewis M., and Vasilenko P. Streptozocin diabetes alters immunoreactive beta-endorphin levels and pain perception after 8 wk in female rats. Diabetes 35 (1986) 1309
21. Fox A., Eastwood C., Gentry C., Manning D., and Urban L. Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain 81 (1999) 307
22. Giesecke T., Gracely R.H., Grant M.A., Nachemson A., Petzke F., Williams D.A., and Clauw D.J. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum. 50 (2004) 613
23. Guilbaud G., Benoist J.M., Levante A., Gautron M., and Willer J.C. Primary somatosensory cortex in rats with pain-related behaviours due to a peripheral mononeuropathy after moderate ligation of one sciatic nerve: Neuronal responsivity to somatic stimulation. Exp. Brain Res. 92 (1992) 227
24. Guilbaud G., Benoist J.M., and Gautron M. Contribution of the sciatic and saphenous nerve to the ventrobasal thalamic neuronal responses to pinch in rats with a chronic sciatic nerve constriction: a study using anesthetic blocks and nerve section. Neurosci. Lett. 187 (1995) 197
25. Gupta P.R., and Dorfman L.J. Spinal somatosensory conduction in diabetes. Neurology 31 (1981) 841
26. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77
27. Kapur D. Neuropathic pain and diabetes. Diabetes/Metab. Rev. 19 Suppl 1 (2003) S9 (Review, 45 refs)
28. Keymeulen B., de Metz K., Cluydts R., Bossuyt A., and Somers G. Technetium-99m hexamethylpropylene amine oxime single-photon emission tomography of regional cerebral blood flow in insulin-dependent diabetes. Eur. J. Nucl. Med. 23 (1996) 163-168
29. Klemm W.R., and Klemm W.R. Habenular and interpeduncularis nuclei: shared components in multiple-function networks. Med. Sci. Monit. 10 (2004) RA261-RA273
30. Lee J.H., and McCarty R. Pain threshold in diabetic rats: effects of good versus poor diabetic control. Pain 50 (1992) 231
31. Llewelyn J.G., Gilbey S.G., Thomas P.K., King R.H., Muddle J.R., and Watkins P.J. Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. A clinicopathological study. Brain 114 (1991) 867
32. MacLeod K.M., Hepburn D.A., Deary I.J., Goodwin G.M., Dougall N., Ebmeier K.P., and Frier B.M. Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia. Diabetologia 37 (1994) 257-263
33. Malik R.A., Veves A., Walker D., Siddique I., Lye R.H., Schady W., and Boulton A.J.M. Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol. 101 (2001) 367
34. Mantyh P.W. Forebrain projections to the periaqueductal gray in the monkey, with observations in the cat and rat. J. Comp. Neurol. 206 (1982) 146-158
35. Millan M.J. Descending control of pain. Prog. Neurobiol. 66 (2002) 355
36. Mokdad A.H., Ford E.S., Bowman B.A., Nelson D.E., Engelgau M.M., Vinicor F., and Marks J.S. Diabetes trends in the U.S.: 1990-1998. Diabetes Care 23 (2000) 1278-1283
37. Morrow T.J., Paulson P.E., Brewer K.L., Yezierski R.P., and Casey K.L. Chronic, selective forebrain responses to excitotoxic dorsal horn injury. Exp. Neurol. 161 (2000) 220-226
38. NIH Guide for the care and use of laboratory animals (1996), National Academy Press Inc., Washington D.C.
39. Paulson P.E., Morrow T.J., and Casey K.L. Bilateral behavioral and regional cerebral blood flow changes during painful peripheral mononeuropathy in the rat. Pain 84 (2001) 233-245
40. Paulson P.E., Casey K.L., and Morrow T.J. Long term changes in behavior and regional cerebral blood flow associated with painful peripheral mononeuropathy in the rat. Pain 95 (2002) 31
41. Paulson P.E., Gorman A.L., Yerzierski R.P., Casey K.L., and Morrow T.J. Differences in forebrain activation in two strains of rat at rest and after spinal cord injury. Exp. Neurol. 196 (2006) 413-421
42. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, New York
43. Pertovaara A., Wei H., Kalmari J., and Ruotsalainen M. Pain behavior and response properties of spinal dorsal horn neurons following experimental diabetic neuropathy in the rat: modulation by nitecapone, a COMT inhibitor with antioxidant properties. Exp. Neurol. 167 (2001) 425
44. Quirce R., Carril J.M., Jimenez-Bonilla J.F., Amado J.A., Gutierrez-Mendiguchia C., Banzo I., Blanco I., Uriarte I., and Montero A. Semi-quantitative assessment of cerebral blood flow with 99mTc-HMPAO SPET in type I diabetic patients with no clinical history of cerebrovascular disease. Eur. J. Nucl. Med. 24 (1997) 1507-1513
45. Raz I., Hasdai D., Seltzer Z., and Melmed R.N. Effect of hyperglycemia on pain perception and on efficacy of morphine analgesia in rats. Diabetes 37 (1988) 1253
46. Rossi P., Morano S., Serrao M., Gabriele A., Di Mario U., Morocutti C., and Pozzessere G. Pre-perceptual pain sensory responses (N1 component) in type 1 diabetes mellitus. NeuroReport 13 (2002) 1009
47. Sima A.A.F., and Li Z.-G. The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1. Diabetic Rats (2005) 1497-1505
48. Sima A.A., and Sugimoto K. Experimental diabetic neuropathy: an update. Diabetologia 42 (1999) 773
49. Sorensen L., Molyneaux L., Yue D.K., Sorensen L., Molyneaux L., and Yue D.K. The level of small nerve fiber dysfunction does not predict pain in diabetic neuropathy: a study using quantitative sensory testing. Clin. J. Pain 22 (2006) 261-265
50. Spruce M.C., Potter J., and Coppini D.V. The pathogenesis and management of painful diabetic neuropathy: a review. Diabet. Med. 20 (2003) 88-98
51. Srinivasan S., Stevens M., and Wiley J.W. Diabetic peripheral neuropathy-evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 49 (2000) 1932
52. Willis W.D. Central plastic responses to pain. Prog. Pain Res. Manag. (1994) 301
53. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109